Furthermore, SNPs within PARP, RAD51, MUTYH, OGG1, PCNA, TPMT, and XPC were associated with disease progression in patients with MM who underwent HDM treatment and ASCT [44]. This evidence concerns the gene RAD51 and Miyoshi myopathy.